Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.02 EUR
Change Today +0.027 / 1.35%
Volume 0.0
VIU On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:11 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Y. Tam

Former President, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

50--
As of Fiscal Year 2013

Background*

Mr. Peter Y. Tam served as the President of VIVUS Inc. from November 3, 2009 to October 12, 2013. Mr. Tam served as the Chief Operating Officer of VIVUS, Inc. since December 2009 and as its Senior Vice President of Product & Corporate Development from August 10, 2004 to January 2009. He served as Vice President of Strategic Planning and Corporate Development for VIVUS Inc. from November 2002 to August 2004. He joined VIVUS Inc. in 1993 as Manager of Clinical Research ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

2009-2013
Former President

Education*

BS 1986
University of California Berkeley
MBA
Santa Clara University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIU:GR €2.02 EUR +0.027

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$746.8K
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
--
Zubair Ahmed Managing Director, Senior Vice President of Indian Sub Continent, Executive Director and Member of Whistle Blower Committee
GlaxoSmithKline Consumer Healthcare Limited
97.4M
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
$640.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.